Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Immunological Methods|October 26, 2007
A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clonesSeung-Tae Lee, Shujuan Liu, Laszlo Radvanyi, et al.
Frontiers in Immunology|October 20, 2017
Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer ImmunotherapyDinler A Antunes, Maurício M Rigo, Martiela V Freitas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2012
Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotypeRichard C Wu, Shujuan Liu, Jessica A Chacon, et al.
Sarcoma|February 24, 2015
Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcomaWilliam W Tseng, Shruti Malu, Minying Zhang, et al.
The Journal of Clinical Investigation|February 9, 2008
Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in miceChengwen Liu, Yanyan Lou, Gregory Lizée, et al.
Cancer Immunology Research|March 22, 2015
BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of MelanomaSherille D Bradley, Zeming Chen, Brenda Melendez, et al.
Cancer Immunology Research|June 21, 2017
SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune ToxicityJungsun Park, Amjad H Talukder, Seon A Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2012
Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanomaJahan S Khalili, Shujuan Liu, Tania G Rodríguez-Cruz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2012
BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in miceChengwen Liu, Weiyi Peng, Chunyu Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2013
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanomaDennie T Frederick, Adriano Piris, Alexandria P Cogdill, et al.
Pageof 6